Log in
NASDAQ:VNDA

Vanda Pharmaceuticals News Headlines

$12.41
+0.30 (+2.48 %)
(As of 11/30/2020 08:40 AM ET)
Add
Compare
Today's Range
$12.01
Now: $12.41
$12.44
50-Day Range
$10.02
MA: $11.51
$13.25
52-Week Range
$7.12
Now: $12.41
$17.85
Volume7,970 shs
Average Volume646,583 shs
Market Capitalization$678.73 million
P/E Ratio5.94
Dividend YieldN/A
Beta0.48

Headlines

Vanda Pharmaceuticals (NASDAQ VNDA) News Headlines Today

Source:
SourceHeadline
Zacks Investment Research Upgrades Vanda Pharmaceuticals (NASDAQ:VNDA) to BuyZacks Investment Research Upgrades Vanda Pharmaceuticals (NASDAQ:VNDA) to Buy
marketbeat.com - November 28 at 9:46 AM
Vanda Pharmaceuticals (NASDAQ:VNDA) Lifted to Buy at Zacks Investment ResearchVanda Pharmaceuticals (NASDAQ:VNDA) Lifted to Buy at Zacks Investment Research
marketbeat.com - October 31 at 1:15 PM
Vanda Pharmaceuticals (NASDAQ:VNDA) Rating Lowered to Strong Sell at BidaskClubVanda Pharmaceuticals (NASDAQ:VNDA) Rating Lowered to Strong Sell at BidaskClub
marketbeat.com - September 3 at 4:33 AM
Vanda Pharmaceuticals (NASDAQ:VNDA) Rating Lowered to Sell at BidaskClubVanda Pharmaceuticals (NASDAQ:VNDA) Rating Lowered to Sell at BidaskClub
marketbeat.com - August 19 at 4:11 AM
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA DecisionsThe Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
benzinga.com - November 29 at 9:25 AM
Attention Biotech Investors: Mark Your Calendar For December PDUFA DatesAttention Biotech Investors: Mark Your Calendar For December PDUFA Dates
feeds.benzinga.com - November 28 at 1:59 PM
Attention Biotech Investors: Mark Your Calendar For December PDUFA DatesAttention Biotech Investors: Mark Your Calendar For December PDUFA Dates
feeds.benzinga.com - November 28 at 1:59 PM
Vanda Pharmaceuticals (NASDAQ:VNDA) Trading 8.9% Higher Vanda Pharmaceuticals (NASDAQ:VNDA) Trading 8.9% Higher
americanbankingnews.com - November 10 at 11:18 PM
Vanda ‘optimistic’ after Q3 sales bump, good news from FDA on new eye inflammation drugVanda ‘optimistic’ after Q3 sales bump, good news from FDA on new eye inflammation drug
bizjournals.com - October 29 at 6:41 PM
Benzingas Top Upgrades, Downgrades For October 29, 2020Benzinga's Top Upgrades, Downgrades For October 29, 2020
finance.yahoo.com - October 29 at 1:41 PM
Vanda Pharmaceuticals EPS beats by $0.01, misses on revenueVanda Pharmaceuticals EPS beats by $0.01, misses on revenue
seekingalpha.com - October 28 at 6:51 PM
Vanda Pharmaceuticals Reports Third Quarter 2020 Financial ResultsVanda Pharmaceuticals Reports Third Quarter 2020 Financial Results
finance.yahoo.com - October 28 at 6:51 PM
Vanda Pharmaceuticals (VNDA) Q3 Earnings Surpass EstimatesVanda Pharmaceuticals (VNDA) Q3 Earnings Surpass Estimates
finance.yahoo.com - October 28 at 6:51 PM
Vanda Pharma on go with mid-stage allergic conjunctivitis studyVanda Pharma on go with mid-stage allergic conjunctivitis study
seekingalpha.com - October 27 at 7:17 AM
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic ConjunctivitisVanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic Conjunctivitis
finance.yahoo.com - October 26 at 8:27 PM
Vanda Pharmaceuticals to Announce Third Quarter 2020 Financial Results on October 28, 2020Vanda Pharmaceuticals to Announce Third Quarter 2020 Financial Results on October 28, 2020
finance.yahoo.com - October 21 at 6:33 PM
Vanda Pharmaceuticals Inc. Regi (VM4.SG)Vanda Pharmaceuticals Inc. Regi (VM4.SG)
au.finance.yahoo.com - October 12 at 12:29 AM
Vanda Pharmaceuticals IncVanda Pharmaceuticals Inc
bloomberg.com - October 2 at 10:58 PM
Vanda Pharma issues developmental plans for tradipitantVanda Pharma issues developmental plans for tradipitant
seekingalpha.com - September 1 at 8:07 AM
Vanda Pharmaceuticals Provides Update on Tradipitant Development ProgramVanda Pharmaceuticals Provides Update on Tradipitant Development Program
finance.yahoo.com - August 31 at 7:50 PM
Vandas experimental COVID-19 drug shows promise in interim trial dataVanda's experimental COVID-19 drug shows promise in interim trial data
nasdaq.com - August 20 at 3:54 AM
ALBO Drops NASH Drug Development, FDA Says No To Filgotinib, SUPN On Watch, Vanda & ODYSSEYALBO Drops NASH Drug Development, FDA Says No To Filgotinib, SUPN On Watch, Vanda & ODYSSEY
nasdaq.com - August 19 at 1:11 AM
Vanda Pharmas Big Step Forward in COVID-19 PneumoniaVanda Pharma's Big Step Forward in COVID-19 Pneumonia
247wallst.com - August 18 at 3:10 PM
Would Shareholders Who Purchased Vanda Pharmaceuticals'(NASDAQ:VNDA) Stock Three Years Be Happy With The Share price Today?Would Shareholders Who Purchased Vanda Pharmaceuticals'(NASDAQ:VNDA) Stock Three Years Be Happy With The Share price Today?
finance.yahoo.com - August 18 at 3:10 PM
Vandas tradipitant shows encouraging action in hospitalized COVID-19 patientsVanda's tradipitant shows encouraging action in hospitalized COVID-19 patients
seekingalpha.com - August 18 at 10:10 AM
Vanda Pharmaceuticals' Interim Analysis from ODYSSEY Study Shows Tradipitant may Accelerate Clinical Improvement in Patients with COVID-19 PneumoniaVanda Pharmaceuticals' Interim Analysis from ODYSSEY Study Shows Tradipitant may Accelerate Clinical Improvement in Patients with COVID-19 Pneumonia
finance.yahoo.com - August 18 at 10:10 AM
Vanda Pharmaceuticals Is Still Undervalued Despite Strong Performance During The PandemicVanda Pharmaceuticals Is Still Undervalued Despite Strong Performance During The Pandemic
seekingalpha.com - August 12 at 8:52 AM
Oil Down But OPEC+ Member Cuts Cap LossesOil Down But OPEC+ Member Cuts Cap Losses
finance.yahoo.com - August 7 at 1:30 AM
Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q2 2020 Results - Earnings Call TranscriptVanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 5 at 11:41 PM
Vanda Pharmaceuticals (VNDA) Q2 Earnings Surpass EstimatesVanda Pharmaceuticals (VNDA) Q2 Earnings Surpass Estimates
finance.yahoo.com - August 5 at 11:41 PM
Vanda Pharmaceuticals Reports Second Quarter 2020 Financial ResultsVanda Pharmaceuticals Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 5 at 6:40 PM
Vanda steps closer to potential FDA approval for rare developmental disorder treatmentVanda steps closer to potential FDA approval for rare developmental disorder treatment
bizjournals.com - August 3 at 3:33 PM
Vanda Pharma nabs accelerated review in U.S. for Hetlioz applicationsVanda Pharma nabs accelerated review in U.S. for Hetlioz applications
seekingalpha.com - August 3 at 10:33 AM
Vanda Pharmas Hetlioz nabs accelerated review in U.S. for rare developmental disorderVanda Pharma's Hetlioz nabs accelerated review in U.S. for rare developmental disorder
seekingalpha.com - August 3 at 10:33 AM
FDA Accepts and Grants Priority Review of Vandas Applications for HETLIOZ® (tasimelteon) in the Treatment of Smith-Magenis SyndromeFDA Accepts and Grants Priority Review of Vanda's Applications for HETLIOZ® (tasimelteon) in the Treatment of Smith-Magenis Syndrome
www.prnewswire.com - August 3 at 7:31 AM
Vanda Pharmaceuticals to Announce Second Quarter 2020 Financial Results on August 5, 2020Vanda Pharmaceuticals to Announce Second Quarter 2020 Financial Results on August 5, 2020
finance.yahoo.com - July 29 at 5:15 PM
Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Vanda Pharmaceuticals Inc. (VNDA)Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Vanda Pharmaceuticals Inc. (VNDA)
finance.yahoo.com - July 21 at 6:45 PM
FDA Grants Extra Access to Vandas Tradipitant to a PatientFDA Grants Extra Access to Vanda's Tradipitant to a Patient
www.nasdaq.com - July 14 at 3:14 PM
FDA Grants Extra Access to Vanda's Tradipitant to a PatientFDA Grants Extra Access to Vanda's Tradipitant to a Patient
finance.yahoo.com - July 14 at 3:14 PM
FDA OKs single-patient expanded access to Vandas tradipitantFDA OKs single-patient expanded access to Vanda's tradipitant
seekingalpha.com - July 13 at 6:10 PM
FDA grants authorization for Individual Patient Expanded Access Protocol for the use of tradipitant for gastroparesisFDA grants authorization for Individual Patient Expanded Access Protocol for the use of tradipitant for gastroparesis
finance.yahoo.com - July 13 at 6:10 PM
Vanda Pharmaceuticals Inc. (VNDA): Hedge Funds Sticking AroundVanda Pharmaceuticals Inc. (VNDA): Hedge Funds Sticking Around
finance.yahoo.com - June 19 at 4:43 PM
Vanda PharmaceuticalsVanda Pharmaceuticals
www.fool.com - June 17 at 3:00 PM
Why Vandas Stock Is Trading Lower TodayWhy Vanda's Stock Is Trading Lower Today
www.benzinga.com - June 9 at 1:08 PM
Vanda Pharmaceuticals Announces Virtual 2020 Stockholder MeetingVanda Pharmaceuticals Announces Virtual 2020 Stockholder Meeting
finance.yahoo.com - May 26 at 8:07 AM
Vanda Pharmaceuticals Wins Motion To Dismiss False Claims Act LawsuitVanda Pharmaceuticals Wins Motion To Dismiss False Claims Act Lawsuit
finance.yahoo.com - May 20 at 9:35 PM
Vanda Pharmaceuticals CEOs Proposal on Clinical Trial Data Sharing, COVID-19 and RemdesivirVanda Pharmaceuticals CEO's Proposal on Clinical Trial Data Sharing, COVID-19 and Remdesivir
finance.yahoo.com - May 20 at 11:33 AM
Vanda Pharmaceuticals CEO's Proposal on Clinical Trial Data Sharing, COVID-19 and RemdesivirVanda Pharmaceuticals CEO's Proposal on Clinical Trial Data Sharing, COVID-19 and Remdesivir
finance.yahoo.com - May 20 at 11:33 AM
1 Pharma Stock to Avoid at All Costs1 Pharma Stock to Avoid at All Costs
finance.yahoo.com - May 15 at 1:06 PM
This Under-the-Radar Drug Developer May Have an Answer for Patients With Severe COVID-19This Under-the-Radar Drug Developer May Have an Answer for Patients With Severe COVID-19
finance.yahoo.com - May 14 at 10:08 AM
Vanda gets nod to submit drug application that FDA previously refusedVanda gets nod to submit drug application that FDA previously refused
www.bizjournals.com - May 13 at 3:17 PM
Vanda on go to refile Hetlioz application in U.S.Vanda on go to refile Hetlioz application in U.S.
seekingalpha.com - May 13 at 10:15 AM
Vanda Pharmaceuticals Announces Agreement with FDA on Resubmission of the Application for HETLIOZ® for the Treatment of Patients with Smith-Magenis SyndromeVanda Pharmaceuticals Announces Agreement with FDA on Resubmission of the Application for HETLIOZ® for the Treatment of Patients with Smith-Magenis Syndrome
finance.yahoo.com - May 13 at 10:15 AM
Vanda: 1Q Earnings SnapshotVanda: 1Q Earnings Snapshot
finance.yahoo.com - May 7 at 3:55 PM
This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.